Published in Curr Top Microbiol Immunol on January 01, 2008
Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation. Nat Chem Biol (2009) 2.52
Microanatomy at cellular resolution and spatial order of physiological differentiation in a bacterial biofilm. MBio (2013) 2.43
Dual role for pilus in adherence to epithelial cells and biofilm formation in Streptococcus agalactiae. PLoS Pathog (2009) 2.15
The BLUF-EAL protein YcgF acts as a direct anti-repressor in a blue-light response of Escherichia coli. Genes Dev (2009) 1.69
Multiple factors modulate biofilm formation by the anaerobic pathogen Clostridium difficile. J Bacteriol (2012) 1.47
Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era. Cold Spring Harb Perspect Med (2013) 1.38
Molecular basis of in vivo biofilm formation by bacterial pathogens. Chem Biol (2012) 1.23
Small Regulatory RNAs in the Control of Motility and Biofilm Formation in E. coli and Salmonella. Int J Mol Sci (2013) 1.16
Growth dynamics and the evolution of cooperation in microbial populations. Sci Rep (2012) 1.15
Small RNAs in the control of RpoS, CsgD, and biofilm architecture of Escherichia coli. RNA Biol (2014) 1.07
Cytoplasmic pH response to acid stress in individual cells of Escherichia coli and Bacillus subtilis observed by fluorescence ratio imaging microscopy. Appl Environ Microbiol (2012) 1.07
Sum of the parts: composition and architecture of the bacterial extracellular matrix. J Mol Biol (2013) 1.01
Automated force volume image processing for biological samples. PLoS One (2011) 1.01
The unexhausted potential of E. coli. Elife (2015) 0.96
Small RNAs and their role in biofilm formation. Trends Microbiol (2012) 0.95
Apple flavonoid phloretin inhibits Escherichia coli O157:H7 biofilm formation and ameliorates colon inflammation in rats. Infect Immun (2011) 0.94
Increased transfer of a multidrug resistance plasmid in Escherichia coli biofilms at the air-liquid interface. Appl Environ Microbiol (2011) 0.92
Life on the outside: role of biofilms in environmental persistence of Shiga-toxin producing Escherichia coli. Front Microbiol (2014) 0.91
Enhanced biofilm formation by Escherichia coli LPS mutants defective in Hep biosynthesis. PLoS One (2012) 0.91
An Escherichia coli Nissle 1917 missense mutant colonizes the streptomycin-treated mouse intestine better than the wild type but is not a better probiotic. Infect Immun (2013) 0.86
Fungal β-1,3-glucan increases ofloxacin tolerance of Escherichia coli in a polymicrobial E. coli/Candida albicans biofilm. Antimicrob Agents Chemother (2015) 0.86
Massive diversification in aging colonies of Escherichia coli. J Bacteriol (2014) 0.85
The ins and outs of RND efflux pumps in Escherichia coli. Front Microbiol (2015) 0.84
Physiochemical properties of Caulobacter crescentus holdfast: a localized bacterial adhesive. J Phys Chem B (2013) 0.84
Biofilm formation by Clostridium difficile. Gut Microbes (2013) 0.84
TolC promotes ExPEC biofilm formation and curli production in response to medium osmolarity. Biomed Res Int (2014) 0.83
What does it take to stick around? Molecular insights into biofilm formation by uropathogenic Escherichia coli. Virulence (2012) 0.82
Potentially pathogenic Escherichia coli can form a biofilm under conditions relevant to the food production chain. Appl Environ Microbiol (2013) 0.82
BolA is a transcriptional switch that turns off motility and turns on biofilm development. MBio (2015) 0.82
Adhesins Involved in Attachment to Abiotic Surfaces by Gram-Negative Bacteria. Microbiol Spectr (2015) 0.82
Type 1 fimbriae contribute to catheter-associated urinary tract infections caused by Escherichia coli. J Bacteriol (2013) 0.81
Construction and characterization of an Escherichia coli mutant producing Kdo₂-lipid A. Mar Drugs (2014) 0.81
Novel reporter for identification of interference with acyl homoserine lactone and autoinducer-2 quorum sensing. Appl Environ Microbiol (2015) 0.81
Antibody-mediated immobilization of Cryptococcus neoformans promotes biofilm formation. Appl Environ Microbiol (2009) 0.81
Did I pick the right colony? Pitfalls in the study of regulation of the phase variable antigen 43 adhesin. PLoS One (2013) 0.80
Fewer Bacteria Adhere to Softer Hydrogels. ACS Appl Mater Interfaces (2015) 0.80
Lysogenic conversion and phage resistance development in phage exposed Escherichia coli biofilms. Viruses (2013) 0.79
Optimisation of engineered Escherichia coli biofilms for enzymatic biosynthesis of l-halotryptophans. AMB Express (2013) 0.79
Identification of commensal Escherichia coli genes involved in biofilm resistance to pathogen colonization. PLoS One (2013) 0.79
PafR, a novel transcription regulator, is important for pathogenesis in uropathogenic Escherichia coli. Infect Immun (2014) 0.78
The Biology of the Escherichia coli Extracellular Matrix. Microbiol Spectr (2015) 0.78
The different ecological niches of enterotoxigenic Escherichia coli. Environ Microbiol (2015) 0.78
Highly Effective Inhibition of Biofilm Formation by the First Metagenome-Derived AI-2 Quenching Enzyme. Front Microbiol (2016) 0.78
Characterizing pilus-mediated adhesion of biofilm-forming E. coli to chemically diverse surfaces using atomic force microscopy. Langmuir (2013) 0.78
Transcriptional profiling of Klebsiella pneumoniae defines signatures for planktonic, sessile and biofilm-dispersed cells. BMC Genomics (2016) 0.78
Effects of Carbon Dioxide Aerosols on the Viability of Escherichia coli during Biofilm Dispersal. Sci Rep (2015) 0.78
Synthetic arabinomannan glycolipids impede mycobacterial growth, sliding motility and biofilm structure. Glycoconj J (2016) 0.77
Bottom-up and top-down solid-state NMR approaches for bacterial biofilm matrix composition. J Magn Reson (2015) 0.77
Genome sequence of multidrug-resistant Escherichia coli EC302/04, isolated from a human tracheal aspirate. J Bacteriol (2012) 0.77
Crowning: a novel Escherichia coli colonizing behaviour generating a self-organized corona. BMC Res Notes (2014) 0.77
Genomic and Functional Portrait of a Highly Virulent, CTX-M-15-Producing H30-Rx Subclone of Escherichia coli Sequence Type 131. Antimicrob Agents Chemother (2015) 0.77
Bacterial surface appendages strongly impact nanomechanical and electrokinetic properties of Escherichia coli cells subjected to osmotic stress. PLoS One (2011) 0.76
Essential Oils and Eugenols Inhibit Biofilm Formation and the Virulence of Escherichia coli O157:H7. Sci Rep (2016) 0.75
Pseudomonas aeruginosa promotes Escherichia coli biofilm formation in nutrient-limited medium. PLoS One (2014) 0.75
Differential Attachment of Salmonella enterica and Enterohemorrhagic Escherichia coli to Alfalfa, Fenugreek, Lettuce, and Tomato Seeds. Appl Environ Microbiol (2017) 0.75
Diversification of Gene Expression during Formation of Static Submerged Biofilms by Escherichia coli. Front Microbiol (2016) 0.75
The virulence factor ychO has a pleiotropic action in an Avian Pathogenic Escherichia coli (APEC) strain. BMC Microbiol (2016) 0.75
Global gene expression in Escherichia coli, isolated from the diseased ocular surface of the human eye with a potential to form biofilm. Gut Pathog (2017) 0.75
Biofilm-Forming Abilities of Shiga Toxin-Producing Escherichia coli Isolates Associated with Human Infections. Appl Environ Microbiol (2015) 0.75
Microbial adhesion and biofilm formation on microfiltration membranes: a detailed characterization using model organisms with increasing complexity. Biomed Res Int (2013) 0.75
Disruption of rcsB by a duplicated sequence in a curli-producing Escherichia coli O157:H7 results in differential gene expression in relation to biofilm formation, stress responses and metabolism. BMC Microbiol (2017) 0.75
Chemotaxis towards autoinducer 2 mediates autoaggregation in Escherichia coli. Nat Commun (2016) 0.75
The Differential Effects of Anesthetics on Bacterial Behaviors. PLoS One (2017) 0.75
Evidence for Escherichia coli Diguanylate Cyclase DgcZ Interlinking Surface Sensing and Adhesion via Multiple Regulatory Routes. J Bacteriol (2016) 0.75
Staphylococcus aureus and Staphylococcus epidermidis Virulence Strains as Causative Agents of Persistent Infections in Breast Implants. PLoS One (2016) 0.75
Escherichia coli O157:H7 Acid Sensitivity Correlates with Flocculation Phenotype during Nutrient Limitation. Front Microbiol (2017) 0.75
The regulator RamA influences cmytA transcription and cell morphology of Corynebacterium ammoniagenes. Curr Microbiol (2010) 0.75
Oxygen-Free Condition Inhibited Biofilm Formation in Extraintestinal Pathogenic Escherichia coli Strain PPECC42 Through Preventing Curli Production. Curr Microbiol (2016) 0.75
Transcriptomic analysis displays the effect of (-)-roemerine on the motility and nutrient uptake in Escherichia coli. Curr Genet (2016) 0.75
Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature (2001) 23.49
Microbial biofilms. Annu Rev Microbiol (1995) 21.58
Pathogenic Escherichia coli. Nat Rev Microbiol (2004) 17.81
Bacterial biofilms in nature and disease. Annu Rev Microbiol (1987) 16.14
Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci U S A (2002) 13.83
The Effect of Solid Surfaces upon Bacterial Activity. J Bacteriol (1943) 13.59
Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili. Mol Microbiol (1998) 10.07
Biofilms: microbial life on surfaces. Emerg Infect Dis (2002) 7.57
Intracellular bacterial biofilm-like pods in urinary tract infections. Science (2003) 7.10
Biofilms: the matrix revisited. Trends Microbiol (2005) 6.66
Staphylococcus and biofilms. Mol Microbiol (2002) 6.39
GGDEF and EAL domains inversely regulate cyclic di-GMP levels and transition from sessility to motility. Mol Microbiol (2004) 6.13
An invertible element of DNA controls phase variation of type 1 fimbriae of Escherichia coli. Proc Natl Acad Sci U S A (1985) 6.00
Gene structure and extracellular secretion of Neisseria gonorrhoeae IgA protease. Nature (1987) 5.88
The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: purification and structural analysis. J Bacteriol (1996) 5.82
Type V protein secretion pathway: the autotransporter story. Microbiol Mol Biol Rev (2004) 5.80
Signal transduction and regulatory mechanisms involved in control of the sigma(S) (RpoS) subunit of RNA polymerase. Microbiol Mol Biol Rev (2002) 5.60
C-di-GMP: the dawning of a novel bacterial signalling system. Mol Microbiol (2005) 5.41
Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu Rev Biochem (2006) 5.41
Fibronectin binding mediated by a novel class of surface organelles on Escherichia coli. Nature (1989) 5.09
The multicellular morphotypes of Salmonella typhimurium and Escherichia coli produce cellulose as the second component of the extracellular matrix. Mol Microbiol (2001) 5.07
Phase and antigenic variation in bacteria. Clin Microbiol Rev (2004) 5.02
A signaling network reciprocally regulates genes associated with acute infection and chronic persistence in Pseudomonas aeruginosa. Dev Cell (2004) 4.98
Role of a highly conserved bacterial protein in outer membrane protein assembly. Science (2003) 4.78
Mechanisms of cyclic-di-GMP signaling in bacteria. Annu Rev Genet (2006) 4.77
The great escape: structure and function of the autotransporter proteins. Trends Microbiol (1998) 4.72
Natural conjugative plasmids induce bacterial biofilm development. Nature (2001) 4.71
Two regulatory fim genes, fimB and fimE, control the phase variation of type 1 fimbriae in Escherichia coli. EMBO J (1986) 4.58
Analysis of the sequence and gene products of the transfer region of the F sex factor. Microbiol Rev (1994) 4.46
Isolation of an Escherichia coli K-12 mutant strain able to form biofilms on inert surfaces: involvement of a new ompR allele that increases curli expression. J Bacteriol (1998) 4.33
Abiotic surface sensing and biofilm-dependent regulation of gene expression in Escherichia coli. J Bacteriol (1999) 4.26
Exopolysaccharide production is required for development of Escherichia coli K-12 biofilm architecture. J Bacteriol (2000) 4.19
Bap, a Staphylococcus aureus surface protein involved in biofilm formation. J Bacteriol (2001) 4.18
The biochemistry and genetics of capsular polysaccharide production in bacteria. Annu Rev Microbiol (1996) 4.13
Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc Natl Acad Sci U S A (2004) 4.12
Structure, assembly and regulation of expression of capsules in Escherichia coli. Mol Microbiol (1999) 4.05
H-NS: a universal regulator for a dynamic genome. Nat Rev Microbiol (2004) 4.03
The biofilm matrix--an immobilized but dynamic microbial environment. Trends Microbiol (2001) 3.97
Influence of interfaces on microbial activity. Microbiol Rev (1990) 3.87
LuxS quorum sensing: more than just a numbers game. Curr Opin Microbiol (2003) 3.76
The pgaABCD locus of Escherichia coli promotes the synthesis of a polysaccharide adhesin required for biofilm formation. J Bacteriol (2004) 3.73
Molecular switches--the ON and OFF of bacterial phase variation. Mol Microbiol (1999) 3.69
Transcriptome analysis of all two-component regulatory system mutants of Escherichia coli K-12. Mol Microbiol (2002) 3.68
Bacterial adhesion: seen any good biofilms lately? Clin Microbiol Rev (2002) 3.62
Large-scale monitoring of pleiotropic regulation of gene expression by the prokaryotic nucleoid-associated protein, H-NS. Mol Microbiol (2001) 3.60
PilZ domain is part of the bacterial c-di-GMP binding protein. Bioinformatics (2005) 3.59
The Rcs phosphorelay: a complex signal transduction system. Annu Rev Microbiol (2005) 3.51
Organization of the Escherichia coli K-12 gene cluster responsible for production of the extracellular polysaccharide colanic acid. J Bacteriol (1996) 3.51
Quorum sensing Escherichia coli regulators B and C (QseBC): a novel two-component regulatory system involved in the regulation of flagella and motility by quorum sensing in E. coli. Mol Microbiol (2002) 3.48
Biofilm formation and dispersal under the influence of the global regulator CsrA of Escherichia coli. J Bacteriol (2002) 3.41
Global gene expression in Escherichia coli biofilms. Mol Microbiol (2003) 3.33
Cyclic di-GMP as a second messenger. Curr Opin Microbiol (2006) 3.31
Periplasmic stress and ECF sigma factors. Annu Rev Microbiol (2001) 3.21
Is quorum sensing a side effect of diffusion sensing? Trends Microbiol (2002) 3.18
Immunochemical properties of the staphylococcal poly-N-acetylglucosamine surface polysaccharide. Infect Immun (2002) 3.14
Autoinducer 2 controls biofilm formation in Escherichia coli through a novel motility quorum-sensing regulator (MqsR, B3022). J Bacteriol (2006) 3.14
Structure of the translocator domain of a bacterial autotransporter. EMBO J (2004) 3.14
Modulation of flagellar expression in Escherichia coli by acetyl phosphate and the osmoregulator OmpR. J Bacteriol (1995) 3.06
A three-component regulatory system regulates biofilm maturation and type III secretion in Pseudomonas aeruginosa. J Bacteriol (2005) 3.05
Positive regulation of motility and flhDC expression by the RNA-binding protein CsrA of Escherichia coli. Mol Microbiol (2001) 3.05
Global impact of mature biofilm lifestyle on Escherichia coli K-12 gene expression. Mol Microbiol (2004) 2.86
Development and maturation of Escherichia coli K-12 biofilms. Mol Microbiol (2003) 2.86
Biofilm dispersal in Xanthomonas campestris is controlled by cell-cell signaling and is required for full virulence to plants. Proc Natl Acad Sci U S A (2003) 2.85
Genetic analysis of Salmonella enteritidis biofilm formation: critical role of cellulose. Mol Microbiol (2002) 2.85
Multiple control of flagellum biosynthesis in Escherichia coli: role of H-NS protein and the cyclic AMP-catabolite activator protein complex in transcription of the flhDC master operon. J Bacteriol (1999) 2.80
A small RNA acts as an antisilencer of the H-NS-silenced rcsA gene of Escherichia coli. Proc Natl Acad Sci U S A (1995) 2.73
Gene expression in Escherichia coli biofilms. Appl Microbiol Biotechnol (2004) 2.71
Surface sensing and adhesion of Escherichia coli controlled by the Cpx-signaling pathway. Proc Natl Acad Sci U S A (2002) 2.68
Gene transfer occurs with enhanced efficiency in biofilms and induces enhanced stabilisation of the biofilm structure. Curr Opin Biotechnol (2003) 2.68
High rates of conjugation in bacterial biofilms as determined by quantitative in situ analysis. Appl Environ Microbiol (1999) 2.65
CATALYTIC PROPERTIES OF TRYPTOPHANASE, A MULTIFUNCTIONAL PYRIDOXAL PHOSPHATE ENZYME. Proc Natl Acad Sci U S A (1964) 2.65
Regulation of uptake and processing of the quorum-sensing autoinducer AI-2 in Escherichia coli. J Bacteriol (2005) 2.64
CsrA post-transcriptionally represses pgaABCD, responsible for synthesis of a biofilm polysaccharide adhesin of Escherichia coli. Mol Microbiol (2005) 2.61
Developmental pathway for biofilm formation in curli-producing Escherichia coli strains: role of flagella, curli and colanic acid. Environ Microbiol (2000) 2.56
Role for the histone-like protein H-NS in growth phase-dependent and osmotic regulation of sigma S and many sigma S-dependent genes in Escherichia coli. J Bacteriol (1995) 2.55
Overproduction of NlpE, a new outer membrane lipoprotein, suppresses the toxicity of periplasmic LacZ by activation of the Cpx signal transduction pathway. J Bacteriol (1995) 2.52
Genes involved in the synthesis and degradation of matrix polysaccharide in Actinobacillus actinomycetemcomitans and Actinobacillus pleuropneumoniae biofilms. J Bacteriol (2004) 2.46
The outer membrane protein, antigen 43, mediates cell-to-cell interactions within Escherichia coli biofilms. Mol Microbiol (2000) 2.45
Bacterial pili: molecular mechanisms of pathogenesis. Curr Opin Microbiol (2000) 2.43
Fimbrial phase variation in Escherichia coli: dependence on integration host factor and homologies with other site-specific recombinases. J Bacteriol (1987) 2.36
HmsP, a putative phosphodiesterase, and HmsT, a putative diguanylate cyclase, control Hms-dependent biofilm formation in Yersinia pestis. Mol Microbiol (2004) 2.36
Complex regulatory network controls initial adhesion and biofilm formation in Escherichia coli via regulation of the csgD gene. J Bacteriol (2001) 2.35
Characterization of the rdar morphotype, a multicellular behaviour in Enterobacteriaceae. Cell Mol Life Sci (2005) 2.35
A role for exopolysaccharides in the protection of microorganisms from desiccation. Appl Environ Microbiol (1994) 2.33
RcsCDB His-Asp phosphorelay system negatively regulates the flhDC operon in Escherichia coli. Mol Microbiol (2003) 2.33
Cyclic-di-GMP-mediated signalling within the sigma network of Escherichia coli. Mol Microbiol (2006) 2.33
Regulation of acetyl phosphate synthesis and degradation, and the control of flagellar expression in Escherichia coli. Mol Microbiol (1994) 2.26
flu, a metastable gene controlling surface properties of Escherichia coli. J Bacteriol (1980) 2.23
Molecular biology of cellulose production in bacteria. Res Microbiol (2002) 2.23
Regulation cascade of flagellar expression in Gram-negative bacteria. FEMS Microbiol Rev (2003) 2.22
Identification, cloning, and expression of bolA, an ftsZ-dependent morphogene of Escherichia coli. J Bacteriol (1988) 2.22
Integration host factor is required for the DNA inversion that controls phase variation in Escherichia coli. Proc Natl Acad Sci U S A (1987) 2.20
Production of cellulose and curli fimbriae by members of the family Enterobacteriaceae isolated from the human gastrointestinal tract. Infect Immun (2003) 2.18
Depolymerization of beta-1,6-N-acetyl-D-glucosamine disrupts the integrity of diverse bacterial biofilms. J Bacteriol (2005) 2.16
Cell-to-cell signalling in Escherichia coli and Salmonella enterica. Mol Microbiol (2004) 2.15
Spatial patterns of alkaline phosphatase expression within bacterial colonies and biofilms in response to phosphate starvation. Appl Environ Microbiol (1998) 2.12
Regulatory circuitry of the CsrA/CsrB and BarA/UvrY systems of Escherichia coli. J Bacteriol (2002) 2.10
Characterization of the importance of Staphylococcus epidermidis autolysin and polysaccharide intercellular adhesin in the pathogenesis of intravascular catheter-associated infection in a rat model. J Infect Dis (2001) 2.10
Genome-wide profiling of promoter recognition by the two-component response regulator CpxR-P in Escherichia coli. J Biol Chem (2002) 2.09
CpxR/OmpR interplay regulates curli gene expression in response to osmolarity in Escherichia coli. J Bacteriol (2005) 2.04
Localization of FtsI (PBP3) to the septal ring requires its membrane anchor, the Z ring, FtsA, FtsQ, and FtsL. J Bacteriol (1999) 4.87
A rapid method for efficient gene replacement in the filamentous fungus Aspergillus nidulans. Nucleic Acids Res (2000) 4.00
Spinal man after declaration of brain death. Neurosurgery (1991) 2.66
Septal localization of FtsQ, an essential cell division protein in Escherichia coli. J Bacteriol (1999) 2.22
Iron acquisition from heme and hemoglobin by a Serratia marcescens extracellular protein. Proc Natl Acad Sci U S A (1994) 2.14
Protein secretion by Gram-negative bacterial ABC exporters--a review. Gene (1997) 1.86
Secretion of the Serratia marcescens HasA protein by an ABC transporter. J Bacteriol (1994) 1.68
Identification of two components of the Serratia marcescens metalloprotease transporter: protease SM secretion in Escherichia coli is TolC dependent. J Bacteriol (1993) 1.45
An observation linking the origin of plasmaspheric hiss to discrete chorus emissions. Science (2009) 1.38
[Management of patients with long term indwelling catheter: Survey of Limousin general practitioners]. Prog Urol (2011) 1.38
Fission of a multiphase membrane tube. Phys Rev Lett (2004) 1.35
CD46/CD3 costimulation induces morphological changes of human T cells and activation of Vav, Rac, and extracellular signal-regulated kinase mitogen-activated protein kinase. J Immunol (2001) 1.22
Identification and characterization of the hemophore-dependent heme acquisition system of Yersinia pestis. Infect Immun (2001) 1.17
Inhibition by omeprazole of proguanil metabolism: mechanism of the interaction in vitro and prediction of in vivo results from the in vitro experiments. J Pharmacol Exp Ther (1997) 1.15
Characterization of HasB, a Serratia marcescens TonB-like protein specifically involved in the haemophore-dependent haem acquisition system. Mol Microbiol (2001) 1.10
Pharmacokinetics and bioavailability of diacetolol, the main metabolite of acebutolol. Eur J Clin Pharmacol (1981) 1.06
Haemophore-mediated signalling in Serratia marcescens: a new mode of regulation for an extra cytoplasmic function (ECF) sigma factor involved in haem acquisition. Mol Microbiol (2004) 1.03
Pharmacokinetics of ketoprofen in the elderly. Br J Clin Pharmacol (1983) 1.00
[Sensitive method for the determination of acebutolol and its N-acetyl metabolite in biological media by high performance liquid chromatography and fluorescence detection]. J Chromatogr (1978) 0.96
Natural inhibitors of T-cell activation in Hodgkin's disease. Blood (1991) 0.89
Aspiration therapy in septic coronary embolism complicating infectious endocarditis. Heart (2010) 0.89
Spectroscopic studies of the C-terminal secretion signal of the Serratia marcescens haem acquisition protein (HasA) in various membrane-mimetic environments. Eur J Biochem (1997) 0.89
A pharmacokinetic study of acebutolol in aged subjects as compared to young subjects. Gerontology (1983) 0.88
C-terminal secretion signal of an Erwinia chrysanthemi protease secreted by a signal peptide-independent pathway: proton NMR and CD conformational studies in membrane-mimetic environments. Biochemistry (1994) 0.87
Imaging of snapping phenomena. Br J Radiol (2012) 0.87
Otoacoustic detection of risk of early hearing loss in ears with normal audiograms: a 3-year follow-up study. Hear Res (2009) 0.87
Awake fibreoptic intubation under remifentanil and propofol target-controlled infusion. Anaesth Intensive Care (2002) 0.86
Radio and plasma wave observations at Saturn from Cassini's approach and first orbit. Science (2004) 0.85
Pharmacokinetics of acebutolol in patients with all grades of renal failure. Eur J Clin Pharmacol (1980) 0.84
Perfusion defects after pulmonary embolism: risk factors and clinical significance. J Thromb Haemost (2010) 0.84
Comparison of 125I-fibrinogen kinetics and fibrinopeptide A in patients with disseminated neoplasias. Blood (1982) 0.82
[Study of the binding of beta blockers to plasma proteins. Therapeutic consequences]. Acquis Med Recent (1977) 0.82
Restoration of normal interleukin-2 production by CD4+ T cells of human immunodeficiency virus-infected patients after 9 months of highly active antiretroviral therapy. J Infect Dis (1999) 0.82
Azithromycin analogue CSY0073 attenuates lung inflammation induced by LPS challenge. Br J Pharmacol (2014) 0.82
Radiofrequency tonsillotomy versus bipolar scissors tonsillectomy for the treatment of OSAS in children: a prospective study. Eur Ann Otorhinolaryngol Head Neck Dis (2013) 0.81
Craniocervical dural fistula associated with cervical myelopathy: angiographic demonstration of normal venous drainage of the thoracolumbar cord does not rule out diagnosis. AJNR Am J Neuroradiol (1998) 0.81
Protein secretion by gram-negative bacterial ABC exporters. Folia Microbiol (Praha) (1997) 0.81
Metabolism of quinine in children with global malnutrition. Pediatr Res (1996) 0.81
Twenty-year birth prevalence of Down syndrome in Cape Town, South Africa. Paediatr Perinat Epidemiol (1997) 0.81
Natural mode of horizontal transmission of bovine leukemia virus (BLV): the potential role of tabanids (Tabanus spp.). Vet Immunol Immunopathol (1989) 0.81
[Spectrofluorometric determination of a new beta-blocking agent, acebutolol in blood and urine]. Ann Biol Clin (Paris) (1975) 0.80
Pharmacokinetics in man of acebutolol and hydrochlorothiazide as single agents and in combination. Eur J Clin Pharmacol (1983) 0.80
Biochemiluminescence and biomedical applications. Cell Biol Toxicol (1994) 0.79
Vasoconstrictor effects of adrenaline in human septic shock. Anaesth Intensive Care (1991) 0.79
[Spectrofluorimetric estimation in biological fluids of a new beta-blockader: atenolol. Application to its pharmacokinetic study (author's transl)]. Ann Biol Clin (Paris) (1978) 0.79
Pharmacokinetic and pharmacodynamic interactions between nifedipine and propranolol or betaxolol. Int J Clin Pharmacol Ther Toxicol (1986) 0.79
Effects of selective and nonselective beta adrenergic agents on renin secretion in isolated perfused rat kidney. J Pharmacol Exp Ther (1980) 0.79
[Application of a method of analysis using high performance liquid chromatography of isoniazid and acetylisoniazid to determine the phenotype of acetylation]. Ann Biol Clin (Paris) (1988) 0.79
Antihypertensive effect of diacetolol in essential hypertension. Br J Clin Pharmacol (1982) 0.78
Influence of amiodarone on genetically determined drug metabolism in humans. Clin Pharmacol Ther (1991) 0.78
[Value of combined splenic scintigraphy and function test in the evaluation of therapeutic measures in hematologic-oncologic diseases]. Verh Dtsch Ges Inn Med (1969) 0.78
Gas chromatographic analysis of volatile compounds in water and biological samples with an automatic injector. J Chromatogr (1987) 0.77
Systemic bioavailability of acebutolol in man. Biopharm Drug Dispos (1983) 0.77
Neuromuscular blockade and ventilatory failure after cyclosporine. Can J Anaesth (1992) 0.76
The elevator illusion results from the combination of body orientation and egocentric perception. Neurosci Lett (2009) 0.75
Plasma cholinesterase deficiency in a premature neonate. Can J Anaesth (1994) 0.75
On monitoring theophylline in serum and saliva. Pediatr Pulmonol (1990) 0.75
Pharmacokinetics of acebutolol after intravenous bolus administration. Br J Clin Pharmacol (1980) 0.75
Advanced oxidation for indirect potable reuse: a practical application in Australia. Water Sci Technol (2009) 0.75
[Pharmacokinetics of a new antiarrhythmic drug, bunaftine, after oral administration (author's transl)]. Therapie (1982) 0.75
New features of electron phase space holes observed by the THEMIS mission. Phys Rev Lett (2009) 0.75
[Variations in the histamine blood level during hemolytic transfusional shock induced in dogs]. C R Seances Soc Biol Fil (1970) 0.75
[Emergency toxicology: analytic protocol applicable to biolobic media in tentative autolysis]. Eur J Toxicol Environ Hyg (1976) 0.75
[Splenic involvement in Hodgkin's disease: results of splenectomy in 80 cases]. Verh Dtsch Ges Inn Med (1973) 0.75
[Partial versus radical nephrectomy for renal cell carcinoma involving peri renal fat. Oncological and functional outcomes]. Prog Urol (2012) 0.75
Pharmacokinetics of a sustained-release trimazosin tablet formulation. Am Heart J (1983) 0.75
[Effect of acute hypoxia on the activity of beta adrenergic receptors]. C R Seances Soc Biol Fil (1967) 0.75
[Effect of propranolol on vascular reactions to adrenaline and noradrenaline]. J Physiol (Paris) (1967) 0.75
[Herpes zoster in splenectomized patients with Hodgkin's disease]. Verh Dtsch Ges Inn Med (1976) 0.75
[On the importance of adrenal medulla secretions in the production of hypertension by nicotine]. C R Seances Soc Biol Fil (1969) 0.75
[Effects of propranalol on the vasodilator action of adrenaline at the level of the striated muscle vessels]. C R Seances Soc Biol Fil (1967) 0.75
[Prevention of hepatitis B for staff members in a hemodialysis unit]. Soins (1982) 0.75
[Influence of protein binding on dialysis clearance of several beta-blocking agents in chronically hemodialysed patients]. Therapie (1983) 0.75
[Hydrophilic viscous gauze or matte man-made fiber gauze, comparison with the hydrophilic gauze of the Codex]. Ann Pharm Fr (1969) 0.75
Dynamic modulation of fimbrial extension and FimH-mannose binding force on live bacteria under pH changes: a molecular atomic force microscopy analysis. J Biomed Nanotechnol (2014) 0.75
[Treatment of severe febrile neutropenia (author's transl)]. Dtsch Med Wochenschr (1980) 0.75
[The cytochemial type of leukaemia as a prognostic factor in acute leukaemia (author's transl)]. Klin Wochenschr (1974) 0.75
[Heart involvement in lymphogranulomatosis]. Fortschr Geb Rontgenstr Nuklearmed (1973) 0.75
[Fibrinogen metabolism and plasma fibrinopeptide A in disseminated neoplasms]. Schweiz Med Wochenschr (1979) 0.75
[Skeletal changes in osteomyelofibrosis]. Radiologe (1973) 0.75
[Ketoprofen-aspirin interaction]. Sem Hop (1983) 0.75
The beta-blocking effect of diacetolol in humans and its relationship to plasma levels. Int J Clin Pharmacol Ther Toxicol (1982) 0.75
Late metastasis from renal cell carcinoma to the thyroid and nasal cavity: report of a case. Rev Laryngol Otol Rhinol (Bord) (2013) 0.75
[Incidence of infections following splenectomy, especially in patients with malignant lymphoma]. Verh Dtsch Ges Inn Med (1974) 0.75
[Therapeutic results in cytochemically immature cell leukemias]. Verh Dtsch Ges Inn Med (1973) 0.75
[Role of histamine liberated during the shock induced in dogs by the injection of incompatible heterologous red blood cells]. J Physiol (Paris) (1969) 0.75
[A new dressing: textile papers or non-woven cloths; comparison with hydrophilic Codex gauze]. Ann Pharm Fr (1969) 0.75
[Average steady-state plasma levels with slow release quinidine preparations]. Arch Mal Coeur Vaiss (1979) 0.75
[Combined splenic scintigraphy and function test: a new differential diagnostic criterion in chronic myeloid leukemia and myelofibrosis]. Verh Dtsch Ges Inn Med (1969) 0.75
[Relations between blood he- parin and histamine levels in dogs during shock due to the injection of heterologous erythrocytes]. J Physiol (Paris) (1970) 0.75
A signal peptide-independent protein secretion pathway. Antonie Van Leeuwenhoek (1992) 0.75
[Bartter's syndrome: the long term effects of indomethacin on growth (author's transl)]. Nouv Presse Med (1979) 0.75
Hypoglossal artery associated with homolateral internal carotid artery dissection. J Neuroradiol (2011) 0.75
[Hairy cell leukemia]. Hamatol Bluttransfus (1976) 0.75
[Study of acebutolol dialysis and pharmacokinetic data in patients with renal insufficiency undergoing hemodialysis]. Nouv Presse Med (1975) 0.75
[Vascular action of angiotensin: balance between peripheral vasoconstrictive influences and vasodilating influences of central origin]. C R Seances Soc Biol Fil (1968) 0.75
[Pharmacokinetics of acebutolol in renal failure]. J Urol Nephrol (Paris) (1976) 0.75
[Hydrophillic cellulose cotton-wool. Further presentation obtained with a modified fiber. Comparison with cellulose cotton-wool and Codex cotton]. Ann Pharm Fr (1966) 0.75
[Therapy results in hairy cell leukemia]. Onkologie (1979) 0.75